Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Entz-Werle N"'
Autor:
Corvest V; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France., Marec-Bérard P; Department of Oncology for Child and Adolescent, Centre Léon Bérard, Pediatric Oncology and Hematology Institute (IHOPe), Lyon, France., Lervat C; Centre Oscar Lambret, Unité d'Oncologie Pédiatrique, Lille, France., Pacquement H; Département de Pédiatrie, Institut Curie, Paris, France., Toulmonde M; Département d'Oncologie Médicale, Institut Bergonié, Unités Sarcomes et Phases Précoces, Bordeaux, France., Gentet JC; Department of Pediatric Hematology, Immunology and Oncology, APHM - La Timone Children's Hospital, Marseille, France., Laurence V; Medical Oncology, Adolescents and Young Adults Unit, Institut Curie, Paris, France., Cleirec M; Service d'Oncologie Pédiatrique, Centre Hospitalier Universitaire de Nantes, Nantes, France., Mansuy L; Department of Pediatric Hematology and Oncology, Nancy University Hospital, Vandœuvre-lès-Nancy, France., Bompas E; Department of Medical Oncology, Centre René Gauducheau, Nantes, France., Castex MP; Hémato-Oncologie Pédiatrique, Hôpital des enfants, Toulouse, France., Taque S; Department of Pediatric Onco-Hematology, Rennes University Hospital, Rennes, France., Filhon B; Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France., Tabone MD; Service d'Hémato-Oncologie Pédiatrique, Hôpital Armand Trousseau - AP-HP, Sorbonne Université, Paris, France., Verité C; Department of Pediatric and Adolescent Hematology and Oncology, Pellegrin Hospital, Bordeaux, France., Entz-Werle N; Pédiatrie Onco-Hématologie, Hôpital Universitaire de Strasbourg, Strasbourg, France., Saumet L; Service d'Onco-Hématologie Pédiatrique, Hôpital Arnaud de Villeneuve, Montpellier, France., Guimard G; Department of Paediatric Oncology/Hematology, CHU de Reims, American Hospital, Reims, France., Pondrom M; Department of Pediatric Hemato-Oncology, Nice University Hospital, Nice, France., Chevreau C; Department of Medical Oncology, Institut Claudius Regaud IUCT-O, Toulouse, France., Flandrin J; Service de Gynécologie Adolescente et Jeune Adulte (GYNADO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Duranteau L; Service de Gynécologie Adolescente et Jeune Adulte (GYNADO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France., Rousset-Jablonski C; Département de Chirurgie, Centre Léon Bérard, INSERM U1290, RESearch in HealthcAre PErformance (RESHAPE), Lyon, France., Brugières L; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France., Jimenez M; Research and Development Department, Unicancer, Paris, France., Le Deley MC; Unité de Méthodologie et Biostatistiques, Centre Oscar Lambret, Lille, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France., Gaspar N; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France., Fresneau B; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Apr 15; Vol. 152 (8), pp. 1659-1667. Date of Electronic Publication: 2022 Oct 31.
Autor:
Marchais A; National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Orsay, France.; Department of Oncology for Children and Adolescents, Gustave Roussy, Villejuif, France., Marques da Costa ME; National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Orsay, France., Job B; National Institute for Health and Medical Research (INSERM) US23, Gustave Roussy, Villejuif, France., Abbas R; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Drubay D; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France., Fromigué O; National Institute for Health and Medical Research (INSERM) UMR981, Gustave Roussy, Villejuif, France., Gomez-Brouchet A; Pathology Department, IUCT-Oncopole, CHU and University of Toulouse, Toulouse, France.; National Centre for Scientific Research (CNRS), UMR5089, Toulouse, France., Redini F; Université de Nantes, Phy-OS, UMR_S 1238 Sarcomes osseux et remodelage des tissus calcifiés, Faculté de Médecine, Nantes, France., Droit R; National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Orsay, France., Lervat C; Pediatric Oncology Unit-Adolescents and Young Adults, Centre Oscar Lambret, Lille, France., Entz-Werle N; Pediatric Onco-Hematology Department, University Hospital of Strasbourg, Strasbourg, France.; UMR CNRS 7021, Laboratory Bioimaging and Pathologies, Tumoral Signaling and Therapeutic Targets team, Faculty of Pharmacy, Illkirch, France., Pacquement H; Department of Medical Oncology, Institut Curie, Paris, France., Devoldere C; CHU Amiens-Picardie, Amiens, France., Cupissol D; Department of Medical Oncology, Centre Val d'Aurelle, Montpellier, France., Bodet D; Pediatric Onco-immuno-Hematology Department, CHU Caen, Caen, France., Gandemer V; CHU de Rennes, Hôpital Sud, Rennes, France., Berger M; Department of Pediatric Hematology and Oncology Unit, University Hospital of Saint-Etienne, Saint-Etienne, France., Marec-Berard P; Unité de Traitement de la Douleur de l'Enfant, Centre Léon Bérard, Institut d'Hématologie et d'Oncologie Pédiatrie, Lyon, France., Jimenez M; R&D Unicancer, Paris, France., Vassal G; Department of Oncology for Children and Adolescents, Gustave Roussy, Villejuif, France., Geoerger B; National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Orsay, France.; Department of Oncology for Children and Adolescents, Gustave Roussy, Villejuif, France., Brugières L; Department of Oncology for Children and Adolescents, Gustave Roussy, Villejuif, France., Gaspar N; National Institute for Health and Medical Research (INSERM) U1015, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Orsay, France.; Department of Oncology for Children and Adolescents, Gustave Roussy, Villejuif, France.
Publikováno v:
Cancer research [Cancer Res] 2022 Mar 15; Vol. 82 (6), pp. 974-985.
Autor:
Gaspar N; Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: nathalie.gaspar@gustaveroussy.fr., Campbell-Hewson Q; The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK., Gallego Melcon S; Pediatric Oncology and Hematology Service, University Hospital Vall d'Hebron, Barcelona, Spain., Locatelli F; Department of Pediatric Hematology and Oncology, Ospedale Pediatrico Bambino Gesù, University of Rome, Rome, Italy., Venkatramani R; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, USA., Hecker-Nolting S; Department of Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany., Gambart M; Pediatric Hemato-Oncology Unit, CHU Toulouse - Hôpital des Enfants, URCP, Toulouse, France., Bautista F; Paediatric Haematology-Oncology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Thebaud E; Pediatric Oncology-Hematology and Immunology Department, CHU Nantes - Hôpital Mère-Enfant, Nantes, France., Aerts I; SIREDO Oncology Center, Institut Curie, PSL Research University, Paris, France., Morland B; Department of Paediatric Hematology/Oncology, Birmingham Children's Hospital, Birmingham, UK., Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany., Canete Nieto A; Children's Oncology Unit, Pediatric Service, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Longhi A; Chemotherapy Service, Istituto Ortopedico Rizzoli IRCCS, Bologna, Italy., Lervat C; Pediatric and AYA Oncology Unit, Centre Oscar Lambret Lille, Lille, France., Entz-Werle N; Pediatric Onco-Hematology Unit, Chu Strasbourg-Hôpital Hautepierre, Strasbourg, France., Strauss SJ; Clinical Research Facility, University College London Hospitals NHS Trust, London, UK., Marec-Berard P; Institute of Pediatric Hematology and Oncology, Centre Léon Bérard, Lyon, France., Okpara CE; Clinical Research, Oncology Business Group, Eisai Ltd., Hatfield, UK., He C; Biostatistics, Oncology Business Group, Eisai Inc., Woodcliff Lake, USA., Dutta L; Clinical Research, Oncology Business Group, Eisai Inc., Woodcliff Lake, USA., Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
ESMO open [ESMO Open] 2021 Oct; Vol. 6 (5), pp. 100250. Date of Electronic Publication: 2021 Sep 22.
Autor:
Gaspar N; Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Centre, Villejuif, France. Electronic address: nathalie.gaspar@gustaveroussy.fr., Venkatramani R; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA., Hecker-Nolting S; Klinikum Stuttgart, Olga Hospital, Stuttgart, Germany., Melcon SG; Vall d'Hebron University Hospital, Barcelona, Spain., Locatelli F; Ospedale Pediatrico Bambino Gesù, Sapienza University of Rome, Rome, Italy., Bautista F; Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Longhi A; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Lervat C; Pediatric and AYA Oncology Unit, Centre Oscar Lambret, Lille, France., Entz-Werle N; Chu Strasbourg-Hôpital Hautepierre, Strasbourg, France., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Aerts I; SIREDO Oncology Center, PSL Research University, Institut Curie, Paris, France., Strauss SJ; University College London Hospital, London, UK., Thebaud E; CHU Nantes-Hôpital Mère-Enfant, Nantes, France., Morland B; Birmingham Children's Hospital, Birmingham, UK., Nieto AC; Hospital Universitario y Politecnico La Fe, Valencia, Spain., Marec-Berard P; Centre Léon Bérard, Lyon, France., Gambart M; CHU de Toulouse, Hôpital des Enfants, Toulouse, France., Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany., Okpara CE; Eisai, Hatfield, UK., He C; Eisai, Woodcliff Lake, NJ, USA., Dutta L; Eisai, Woodcliff Lake, NJ, USA., Campbell-Hewson Q; The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Sep; Vol. 22 (9), pp. 1312-1321. Date of Electronic Publication: 2021 Aug 17.
Autor:
Lui G; EA 7323, Université Paris Descartes Sorbonne Paris Cité, Paris, France.; Clinical Pharmacology Department, Cochin Hospital, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France., Treluyer JM; EA 7323, Université Paris Descartes Sorbonne Paris Cité, Paris, France.; Clinical Pharmacology Department, Cochin Hospital, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.; URC, Tarnier Hospital, France., Fresneau B; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France.; Paris-Saclay University, CESP, INSERM, Villejuif, France., Piperno-Neumann S; Medical Oncology Department, Institut Curie, Paris, France., Gaspar N; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France., Corradini N; Pediatric Oncology Department, Mother-Children Hospital, Nantes, France., Gentet JC; Pediatric Oncology Department, La Timone Children's Hospital, Marseille, France., Marec Berard P; Pediatric Oncology Department, Institute of Pediatric Hematology and Oncology-Léon Bérard Anticancer Center, Lyon, France.; Oncology Department, Institut Curie, Paris, France., Laurence V; Medical Oncology Department, Institut Curie, Paris, France., Schneider P; Pediatric Hemato-Oncology Department, University Hospital, Rouen, France., Entz-Werle N; Pediatric Oncology Department, CHU Hautepierre, Strasbourg, France., Pacquement H; Medical Oncology Department, Institut Curie, Paris, France., Millot F; CIC-1402 INSERM, Poitiers, France., Taque S; Department of Pediatric Hemato-Oncology, University Hospital, Rennes, France., Freycon C; Pediatric Department, The Child and Family Hospital, University Hospital, Grenoble, France., Lervat C; Pediatric Oncology Unit, Centre Oscar Lambret, Lille, France., Le Deley MC; Paris-Saclay University, CESP, INSERM, Villejuif, France.; Biostatistics Unit, Gustave Roussy, Villejuif, France., Mahier Ait Oukhatar C; UNICANCER Sarcoma Group, Paris, France., Brugieres L; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France., Le Teuff G; Paris-Saclay University, CESP, INSERM, Villejuif, France.; Biostatistics Unit, Gustave Roussy, Villejuif, France., Bouazza N; EA 7323, Université Paris Descartes Sorbonne Paris Cité, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.; URC, Tarnier Hospital, France.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2018 Dec; Vol. 58 (12), pp. 1541-1549. Date of Electronic Publication: 2018 May 23.
Autor:
Tabone MD; Department of Paediatric Onco-Haematology, Armand Trousseau Hospital, 26 avenue du Dr A. Netter, 75571, Paris cedex12, France. marie-dominique.tabone@aphp.fr.; Department of Paediatric Onco-Haematology AP-HP, GHUEP, Trousseau La Roche-Guyon Hospital, 26 avenue du Dr A. Netter, 75012, Paris, France. marie-dominique.tabone@aphp.fr., Brugières L; Department of Children and adolescents Oncology, Gustave Roussy Cancer campus, 114 rue E. Vaillant, 94805, Villejuif, France., Piperno-Neumann S; Department of Medical Oncology, Curie Institute, 26 rue d'Ulm, 75005, Paris, France., Selva MA; Department of Biochemistry, Armand Trousseau Hospital, 26 avenue du Dr A. Netter, 75571, Paris cedex12, France., Marec-Bérard P; Institute for Paediatric Haematology and Oncology, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Pacquement H; Department of Paediatric Oncology, Curie Institute, 26 rue d'Ulm, 75005, Paris, France., Lervat C; Department of Paediatric Oncology, Oscar Lambret Cancer Centre, 3 rue Frédéric Combemale, 59020, Lille cedex, France., Corradini N; Department of Paediatric Haemato-Oncology, Mother and Child Hospital, 7 quai Moncousu, 44093, Nantes, France., Gentet JC; Department of Paediatric Oncology, La Timone Hospital, 264 rue Saint Pierre, 13385, Marseille cedex 5, France., Couderc R; Department of Biochemistry, Armand Trousseau Hospital, 26 avenue du Dr A. Netter, 75571, Paris cedex12, France., Chevance A; Biostatistics and Epidemiology unit, Gustave Roussy Cancer Campus, 114 rue E. Vaillant, 94805, Villejuif, France., Mahier-Ait Oukhatar C; Department of Clinical Studies, Unicancer, 101 rue de Tolbiac, 75654, 13, Paris cedex, France., Entz-Werle N; Department of Paediatric Oncology, Hautepierre Hospital, 1 avenue Molière, 67100, Strasbourg, France., Blay JY; Department of Medical Oncology, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France.; Claude Bernard University Lyon 1, 43 boulevard du 11 novembre 1918, 69622, Villeurbanne cedex, France., Le Deley MC; Biostatistics and Epidemiology unit, Gustave Roussy Cancer Campus, 114 rue E. Vaillant, 94805, Villejuif, France.; Paris-Saclay University, Univ. Paris-Sud, CESP, INSERM, Gustave Roussy, Villejuif, France.
Publikováno v:
BMC cancer [BMC Cancer] 2017 Jun 15; Vol. 17 (1), pp. 419. Date of Electronic Publication: 2017 Jun 15.
Autor:
Gaspar N; Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France. Nathalie.GASPAR@igr.fr, Rey A, Bérard PM, Michon J, Gentet JC, Tabone MD, Roché H, Defachelles AS, Lejars O, Plouvier E, Schmitt C, Bui B, Boutard P, Taque S, Munzer M, Vannier JP, Plantaz D, Entz-Werle N, Oberlin O
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2012 Jun; Vol. 48 (9), pp. 1376-85. Date of Electronic Publication: 2012 Apr 18.
Autor:
Entz-Werle N; Institut National de la Santé et de la Recherche Médicale U682, Strasbourg, France. natacha.entz-werle@chru-strasbourg.fr, Lavaux T, Metzger N, Stoetzel C, Lasthaus C, Marec P, Kalifa C, Brugieres L, Pacquement H, Schmitt C, Tabone MD, Gentet JC, Lutz P, Babin A, Oudet P, Gaub MP, Perrin-Schmitt F
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2007 Aug; Vol. 9 (8), pp. 678-88.
Autor:
Entz-Werle N; Laboratoire de Biochimie et Biologie Moléculaire, CHRU Hautepierre, 1 Avenue Molière, Strasbourg Cedex, France. natacha.entz-werle@chru-strasbourg.fr, Gaub MP, Lavaux T, Marcellin L, Metzger N, Marec-Berard P, Schmitt C, Brugiere L, Kalifa C, Tabone MD, Pacquement H, Gentet P, Lutz P, Oudet P, Babin A
Publikováno v:
International journal of cancer [Int J Cancer] 2007 Jun 01; Vol. 120 (11), pp. 2510-6.
Autor:
Orosco A; INSERM U606 and Université Paris 7, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris cedex 10, France., Fromigué O, Bazille C, Entz-Werle N, Levillain P, Marie PJ, Modrowski D
Publikováno v:
Cancer research [Cancer Res] 2007 Apr 15; Vol. 67 (8), pp. 3708-15.